Patient's question:
The baby is three and a half months old. Six days after birth, due to jaundice, the baby stayed in the neonatal ward for a week, with indirect bilirubin being the main issue, while other bacteria, viruses, endocrine, and hemolysis were negative. After treatment, the baby recovered and was discharged. Upon discharge, the sclera was still yellow, and later the skin turned yellow again. At two months of age, the jaundice became (obvious), and the baby was hospitalized again. Cytomegalovirus was positive, with urine cytomegalovirus DNA at 4800, while other genetic metabolism issues were normal. After two weeks of ganciclovir antiviral and altorphanol liver protection treatment, a follow-up liver function test showed ALT 113 and AST 92. The baby was discharged and continued oral Tianqing (galactosamine) and ursodeoxycholic acid liver protection treatment. Twenty days later, a follow-up test showed urine cytomegalovirus DNA at 523 and liver function with ALT 140 and AST 91. Is a second course of antiviral treatment necessary? Are there better oral liver protection medications?Doctor's answer:
Currently, infants do not have any antiviral drugs for hepatitis B, and it should only be liver protection and enzyme reduction treatment. However, it is also necessary to understand the amount of virus. Generally, antiviral treatment is not recommended for those under 6 years old, and oral antiviral drugs are not used for those under 12 years old. Interferon can be injected if necessary. It is recommended to complete the HBV-DNA test. Liver protection and immune enhancement treatment can be provided.